NCT07101822: A PHASE II, RANDOMIZED STUDY TO ASSESS MAINTENANCE THERAPY WITH CEMIPLIMAB VERSUS BEST SUPPORTIVE CARE AFTER 1ST LINE PLATINUM-BASED CHEMOTHERAPY IN ADVANCED/RECURRENT PENILE CANCER
- State
- Not started
- Phase
- Phase 2
- People
- 42 planned
- Started
- Dec 2025
- Primary completion
- Dec 2028
- Arms
- Experimental
- Results
- None posted
- 3 Aug 2025: Trial registered